New study sheds light on incidental findings in lung cancer screening

Credit: Pixabay/CC0 Public Domain When patients receive a low-dose computed tomography screen for lung cancer, doctors can see more than just the lungs. The screening test often picks up abnormalities…

Customizing T cell-based immunotherapies using new ‘SNAPtag’ technology

Universal adaptor SNAP-CAR and SNAP-synNotch receptor function. a A benzylguanine motif (BG) is chemically conjugated to an antibody using a benzylguanine NHS ester. The BG-antibody conjugate then covalently binds to…

A new diagnostic approach for breast cancer

Credit: Cordis Breast cancer diagnosis is an area that is constantly evolving, with new innovations emerging to improve patient outcomes. The SOLUS project is one such innovative initiative working to…

Obesity as a risk factor for colorectal cancer underestimated so far, says study

Weight Change Among Cases and Controls Within 12 Years Before Diagnosis/Interview Lower and upper hinges correspond to 25th and 75th quantile of weight changes, respectively; lower and upper whiskers correspond…

Transgender women are still at risk for prostate cancer

Credit: Pixabay/CC0 Public Domain Transgender women keep their prostates even after gender-affirming surgery, but the extent to which they remain at risk of prostate cancer has been unclear. Now a…

Black women die of breast cancer at younger ages. Should they be screened earlier?

Experts recommend that women at least consider starting breast cancer screening once they turn 40. Now a new study suggests that is especially critical for Black women. Looking at data…

Preclinical promise and the unveiling of a prognostic gene signature

Omomyc induces growth arrest in melanoma human cell lines in vitro. (A) Growth inhibition by transgenic Omomyc at 10 d by Crystal Violet staining. (B) Early effect of Omomyc on…

Lung cancer outcomes significantly improved with immunotherapy-based treatment given before and after surgery

Credit: Pixabay/CC0 Public Domain A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone…